CSRxP Statement on HHS OIG Part D Spending Report
Jun 4, 2018
Today, the Office of the Inspector General at the Department of Health and… Read More
© 2024 CSRXP- All Rights Reserved
Updates
CSRxP Applauds FDA’s Focus on REMS Abuses
May 31, 2018
The Campaign for Sustainable Rx Pricing released the following statement… Read More
CSRxP Applauds FDA’s Transparency on Brand “Gaming” Tactics
May 17, 2018
The Campaign for Sustainable Rx Pricing released the following statement… Read More
CSRxP on President Trump’s Remarks on Drug Prices
May 11, 2018
The Campaign for Sustainable Rx Pricing released the following statement… Read More
CSRxP Launches TV & Digital Ad Campaign Urging Congress to Pass the CREATES Act
Mar 8, 2018
March 8, 2018 Contact: [email protected] ( 202) 286-4682 The Campaign for… Read More
CSRxP Statement on Nomination of Alex Azar to be Secretary of Health and Human Services
Nov 17, 2017
The Campaign for Sustainable Rx Pricing released the following statement… Read More
Vizient Joins CSRxP as 30th Member of the Coalition
Sep 21, 2017
“We are excited to join CSRxP and be a part of the coalition to achieve reasonable prescription drug prices,” says Jody Hatcher, president, sourcing and collaboration services at Vizient. “Our health care members are facing enormous financial and clinical pressures associated with pharmaceuticals. Read More
37 Signatories Call on Congress to Pass CREATES Act
Sep 20, 2017
37 signatories have called on Congress to pass the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act. This coalition represents a broad-based and diverse cross-section of stakeholders – including providers and payers, physicians and consumers, businesses and unions – all of whom have come together in strong support of this important legislation. Read More
CSRxP Statement on Novartis’ $475,000 Price Tag for Kymriah
Aug 30, 2017
"While we are very excited about the potential for CAR-T therapies to save lives, Novartis’ pricing decision disappointingly pushes an unsustainable trend even closer to the breaking point." Read More
CSRxP Calls for Action on CREATES Act
Jul 27, 2017
CSRxP Calls for Action on CREATES Act The Campaign for Sustainable Rx Pricing… Read More
CSRxP Calls for Further Action on Rx Prices
Jul 12, 2017
CSRxP spokesman Will Holley releases statement following House passage of FDA user fee legislation. Read More
CSRxP Releases Powerful Testimonial: “Debbie’s Story”
Jul 10, 2017
CSRxP Releases Powerful Testimonial: “Debbie’s Story” The… Read More